New Alliance Capital, also known as 联新资本/ Lianxin Ziben, is a venture capital firm in China that focuses on high-end manufacturing, media, energy, consumer goods, information, recycling, environmental protection technology, advanced agriculture, and modern services industries. Founded in 2008 by Liefeng Qu in Shanghai, China, this company invests in early stage, growth stage and pre-IPO ventures. Its portfolio companies include United Imaging, Shanghai Engineering Cell Therapy, STA Pharma, Thousandaks, Microport, Rapid Medical, Lombard, etc.
New Alliance Capital is still active and as of November 2019, the company made a total of 10 investments. The company’s latest investment was made on Jun 10, 2019. New Alliance Capital had one exit.
Timeline
Funded Companies
Innoviz is a leading manufacturer of high-performance, solid-state LiDAR sensors and perception software that enable the mass-production of autonomous vehicles.
Sight is a blood diagnostic company based in Tel Aviv, Israel.
CooTek is a Shanghai-based mobile application development company.
CF PharmTech is a City of Industry, California-based company.
People
Akane
Investment Team
Li Fei
Investment Team
Liefeng Qu
Founder and partner
Wu Zonghe
Investment Team
Xu Hai
Investment Team
Zhang Nan
Investment Team
Further reading
Documentaries, videos and podcasts
Companies
Thousand Oaks Biopharmaceuticals
Banma Kuaipao
CooTek
Innoviz Technologies
ShopEx
Sight Diagnostics
Sight Diagnostics
Wuhan Zebra Express
ZStack
References
Company attributes
Venture Capital Firm attributes
Categories
Related Topics
Contributors
- 1
Marie Gabrielle Laguna- Bedia
Co-founder and Managing Partner of Eternus Global. Physician of internal medicine, app developer and entrepreneur - 2
Neelam Jhaveri
Techno Geek + Gamer + Fashionista + Sense of Humor = It's ME - 3
Henry Ogolla
Passionate about reading and writing. - 4
Mevludin Mešanović
Bachelor of Electrical Engineering